Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Kanagy, Nancy L ^a,b   Charpie, John R ^a   Dananberg, Jamie ^a   Webb, R Clinton ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

adenosine 5' monophosphate ribosylation; guanosine 3',5' cyclic monophosphate; guanylyl cyclase; vascular smooth muscle

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; CYCLIC AMP; DIETHYLAMINE; GLUTATHIONE; GUANYLATE CYCLASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; COVALENT BOND; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MODIFICATION; EXPOSURE; LIGAND BINDING; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 33750817387     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.1.h253     Document Type: Article

References (28)

1. Banasik, M., and K. Ueda. Inhibitors and activators of ADP-ribosylation reactions. Mol. Cell. Biochem. 138: 185-197, 1994.
2. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature Lond. 368: 850-853, 1994.
3. Brüne, B., S. Dimmeler, L. Molina y Vedia, and E. G. Lapetina. Nitric oxide: a signal for ADP ribosylation of proteins. Life Sci. 54: 61-70, 1994.
4. 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. J. Biol Chem. 269: 5730-5734, 1994.
5. Clancy, R. M., J. Leszczynska-Piziak, and S. B. Abramson. Nitric oxide stimulates the ADP ribosylation of actin in human neutrophils. Biochem. Biophys. Res. Commun. 191: 847-858, 1993.
6. Dananberg, J., R. S. Sider, and R. J. Grekin. Sustained hypertension induced by orally administered nitro-L-arginiae. Hypertension Dallas 21: 359-363, 1993.
7. Doucet, J. P., and B. S. Tauna. Identification of low molecular weight GTP-binding proteins and their sites of interaction in subcellular fractions from skeletal muscle. J. Biol. Chem. 266: 17613-17620, 1991.
8. Du, Z. Y., B. F. Buxton, and O. L. Woodman. Tolerance to glycerol trinitrate in isolated human internal mammary arteries. Thorac. Cardiovasc. Surg. 104: 1280-1284, 1992.
9. Garg, U. C., and A. Hassid. Nitric oxide decreases cytosolic free calcium in Balb/c 3T3 fibroblasts by a cyclic GMP-independeat mechanism. J. Biol. Chem. 266: 9-12, 1991.
10. Gopalakrichna, R., A. H. Chen, and U. Gundimeda. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180-27185, 1993.
11. Jacobson, M. K., P. T. Loflin, N. Aboul-Ela, M. Mingmaung, J. Moss, and E. L. Jobson. Modification of plasma membrane protein cysteine residues by ADP ribose in vivo. J. Biol. Chem. 265: 10825-10858, 1990.
12. Kawamoto, R. M., and A. H. Caswell. Autophosphorylation of glyceraldehydephosphate dehydrogenase and phosphorylation of protein from skeletal muscle microsome. Biochemistry 25: 657-661, 1986.
13. Kim, K. C., A. H. Caswell, J. A. Talvenheimo, and N. R. Brandt. Isolation of a terminal cisterna protein which may link the dihydropyridine receptor to the junctional foot protein in skeletal muscle. Biochemistry 29: 9281-9289, 1990.
14. Lander, H. M., P. K. Sehajpal, and A. Novogrodsky. Nitric oxide signaling: a possible role for G proteins. J. Immunology 151: 7182-7187, 1993.
15. Mandel, P. Some aspects of nuclear and cytoplasmic ADP-ribosylation. Biological and pharmacological perspectives. In: ADP-Ribosylation Reactions, edited by G. G. Poirer and P. Moreau. New York: Springer Verlag, 1992, p. 163-172.
16. Moncada, S. Nitric oxide. J. Hypertens. 12, Suppl. 10: S35-S39, 1994.
17. Moss, J., and M. Vaughan. Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase. Proc. Natl. Acad. Sci. USA 75: 3621-3624, 1978.
18. Obara, S., K. Yamada, Y. Yoshimura, and M. Shimoyama. Evidence for the endogenous GTP-dependent ADP-ribosylation of the alpha-subunit of the stimulatory guanyl-nucleotide-binding protein concomitant with an increase in basal adenylyl cyclase activity in chicken spleen cell membrane. Eur. J. Biochem. 200: 75-80, 1991.
19. Panza, J. A., C. E. García, C. M. Kilcoyne, A. A. Quyyumi, and R. O. Cannon III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91: 1732-1738, 1995.
20. Pozdnyakov, N., A. Lloyd, V. Reddy, and A. Sitaramayya. Nitric oxide-regulated endogenous ADP-ribosylation of rod outer segment proteins. Biochem. Biophys. Res. Commun. 192: 610-615, 1993.
21. Schuman, E. M., M. K. Meffert, H. Schulman, and D. V. Madison. An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc. Natl. Acad. Sci. USA 91: 11958-11962, 1994.
22. Singh, R., and M. R. Green. Sequence specific binding of transfer RNA by glyceraldehyde-3-phosphate-dehydrogenase. Science Wash. DC 259: 365-368, 1993.
23. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
24. Toda, N., Y. Kitamura, and T. Okamura. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension Dallas 21: 3-8, 1993.
25. Watts, S. W., K. M. Finta, M. C. Lloyd, D. S. Storm, and R. C. Webb. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension. Blood Pressure 5: 340-348, 1994.
26. Williamson, K. C., and J. Moss. Mono-ADP-ribosyltransferases and ADP-ribosylarginine hydrolases: a mono-ADP ribosylation cycle in animal cells. In: ADP-Ribosylation Reactions, edited by G. G. Poirier and P. Moreau. New York: Springer-Verlag, 1992, p. 192-236.
27. ω-nitro-L-arginine. Chin. J. Physiol. 34: 257-266, 1991.
28. 1 neurons in slices. Neuropharmacology 34: 75-80, 1995.